Findings in Pseudogout
Pseudogout (CPPD) presents with acute inflammatory arthritis characterized by rapid-onset joint pain and swelling, with definitive diagnosis requiring identification of rhomboid-shaped calcium pyrophosphate dihydrate crystals in synovial fluid under polarized light microscopy 1.
Clinical Presentation
The clinical picture typically includes:
- Acute onset of severe joint pain and swelling, often following mechanical trauma, surgery, infection, or vascular events 2
- Physical examination findings: warmth, joint effusion, tenderness, and markedly limited range of motion 1
- Joint distribution: Oligoarticular or polyarticular involvement in approximately 50% of cases 2, with the knee being the most commonly affected joint (>90% in post-arthroplasty cases) 3
- Systemic symptoms: Fever occurs in about 22% of cases 3
Critical pitfall: The presentation mimics both septic arthritis and gout flares, making it essential to maintain a broad differential diagnosis 1, 3. In prosthetic joints, pseudogout can be clinically indistinguishable from prosthetic joint infection 3.
Laboratory Findings
Laboratory investigations reveal:
- Synovial fluid analysis (gold standard): Identification of rhomboid-shaped, weakly positive birefringent calcium pyrophosphate crystals under polarized light microscopy 1
- Serum markers: Elevated inflammatory markers (ESR, CRP) during acute attacks 4
- Metabolic screening: Check for associated conditions including:
Important caveat: Routine biochemical tests often show no significant differences between pseudogout patients and age-matched controls, and laboratory abnormalities are frequent in elderly populations regardless of CPPD status 6.
Imaging Findings
Conventional Radiography
The 2023 EULAR guidelines emphasize imaging's role in diagnosis 7. Classic radiographic features include:
- Chondrocalcinosis: Linear calcification of cartilage visible in fibrocartilage (menisci, triangular fibrocartilage of wrist), hyaline cartilage, and joint capsules 2, 8
- Pyrophosphate arthropathy: Progressive destructive changes resembling accelerated osteoarthritis, present in approximately one-third of patients 2
- Capsular/periarticular calcifications: Asymptomatic deposits found in about one-third of cases 2
Optimal radiographic technique: For small joints, use industrial Type M film with contact exposure; for large joints, direct radiographic magnification (3-4×) with microfocus tube 8.
Advanced Imaging
- CT: Superior for detecting calcifications, particularly in the spine (e.g., "crowned dens syndrome" at C1-C2) 9
- MRI: Shows inflammatory changes and soft tissue masses but may not visualize calcifications, potentially mimicking tumors or infections 4, 9
- Ultrasound and DECT: Included in recent diagnostic recommendations per EULAR 2023 guidelines 7
Critical diagnostic challenge: Spinal pseudogout can present without visible calcifications on CT while producing mass lesions on MRI that mimic neoplasms or infections, requiring tissue biopsy for definitive diagnosis 4, 9.
Risk Factors to Identify
- Advanced age (prevalence increases dramatically after age 70, reaching 13% across selected populations) 7
- Pre-existing osteoarthritis 1
- History of joint trauma or meniscectomy 1
- Primary hyperparathyroidism 2, 5
- Recent bisphosphonate administration (particularly zoledronic acid) 5
Key clinical pearl: Only a minority of patients (approximately 18% in one series) have a prior history of gout or pseudogout 3, so absence of prior crystal disease does not exclude the diagnosis.